TCT-470 Routine Follow Up Coronary Angiography versus Clinical Follow Up Only in Patients with Multi-vessel Disease following Percutaneous Coronary Intervention with Drug-eluting Stents: 3-year Clinical Follow Up Results  by Rha, Seung-Woon et al.
B192 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 5CONCLUSIONS The use of 2nd generation DES was associated with
similar efﬁcacy proﬁle and improvement in safety performance, with a
marked reduction in MI occurrence.
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BACKGROUND Indication of side branch (SB) intervention after main
vessel (MV) stenting is not established in coronary bifurcation lesions.
METHODS In the Coronary Bifurcation Stenting II Registry, 2,897 pa-
tients undergoing percutaneous coronary intervention using drug-
eluting stents for bifurcation lesions with SB 2.3 mm were enrolled.
We selected 2,017 patients treated with 1-stent technique or MV
stenting ﬁrst strategy. Patients undergoing SB intervention after MV
stenting (SB intervention group, n¼929) were compared to those not
after MV stenting (no-SB intervention group, n¼1,088) in terms of
cardiac death or myocardial infarction (MI).
RESULTS During a median follow-up duration of 37 months, the cu-
mulative rate of cardiac death or MI tended to occur less frequently in
the SB intervention group than in the no-SB intervention group (1.8 %
versus 2.9%; adjusted hazard ratio [HR] 0.56; 95% conﬁdence interval
[CI] 0.29 to 1.07; p¼0.08). There was signiﬁcant interaction between
SB intervention and SB stenosis after MV stenting (p for
interaction <0.01). Of 1,077 patients with diameter stenosis of
SB 50% after MV stenting, SB intervention was associated with a
lower risk of cardiac death or MI (1.2% versus 4.2%; adjusted HR 0.22;
95% CI 0.09 to 0.52; p<0.01). However, among 940 patients with
diameter stenosis of SB <50%, there was no signiﬁcant difference in
cardiac death or MI (3.5% versus 2.2%; adjusted HR 1.36; 95% CI 0.58
to 3.20; p¼0.48) between the two groups.
Table 5. Clinical Outcomes according to residual SB stenosis after MV stenting.SB
interventionNo SB
intervention Unadjusted HRp value1Adjusted HR p
value
(n[670) (n[407) (95% CI) (95% CI)Patients with DS of SB 50% after MV stenting (n¼1,077)
Cardiac death
or MI8 (1.2) 17 (4.2) 0.24 (0.11-0.57) 0.001 0.22 (0.09-0.52) 0.001TLR 53 (7.9) 26 (6.4) 1.07 (0.67-1.71) 0.784 1.04 (0.64-1.68) 0.880SB
interventionNo SB
intervention Unadjusted HRp value2Adjusted HR p
value
(n[259) (n[681) (95% CI) (95% CI)Patients with DS of SB <50% after MV stenting (n¼940)
Cardiac death
or MI9 (3.5) 15 (2.2) 1.50 (0.66-3.43) 0.338 1.36 (0.58-3.20) 0.475TLR 12 (4.6) 35 (5.1) 0.85 (0.44-1.63) 0.620 0.80 (0.41-1.56) 0.510CI ¼ conﬁdence interval; DS ¼ diameter stenosis; HR ¼ hazard ratio; MI ¼ myocardial infarction; MV ¼ main
vessel; SB ¼ side branch; TLR ¼ target lesion revascularization.1Adjusted covariates included bifurcation
location, true bifurcation and MV lesion length before procedure.
2
Adjusted covariates included history of
previous PCI, acute coronary syndrome, and true bifurcation.
CONCLUSIONS Effect of SB intervention seems to differ according to
SB stenosis after MV stenting. SB intervention may reduce cardiac
death or MI in bifurcation lesions with diameter stenosis of SB 50%
after MV stenting.
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BACKGROUND It is unclear whether the routine follow up (FU) cor-
onary angiography (CAG) regardless of patient’s symptoms after suc-
cessful percutaneous coronary intervention (PCI) with drug-eluting
stents (DESs) in patients (pts) with multi-vessel disease (MVD) is
beneﬁcial or not.
METHODS The study population consisted of 642 consecutive MVD
pts underwent PCI with unrestricted utilization of DESs from January
2004 to May 2011. Routine FU CAG was performed between 6 to 9
months following index PCI and was decided by individual physi-
cian’s discretion. Rests of the pts were clinically followed and
ischemic driven events were captured. Clinical events including
mortality, myocardial infarction and clinically driven PCI before 9
months were excluded in both groups. Cumulative clinical outcomes
up to 3 years were compared between the Routine CAG group (n¼374
pts) and the Clinical FU group (n¼ 268 pts). To adjust potential con-
founders, a propensity score matched (PSM) analysis was performed
using the logistic regression model.
RESULTS After PSM analysis, 2 propensity-matched groups (193 pairs,
n ¼ 386 pts, C-statistic¼0.744) were generated and the baseline
characteristics of the two groups were balanced. At 3 years, the inci-
dence of target lesion revascularization (TLR) and target vessel
revascularization (TVR) and major adverse cardiac events (MACEs)
was higher in the Routine CAG group than the control group (Table).
CONCLUSIONS Despite the expected beneﬁcial effects, routine FU
CAG following index PCI with DESs in MVD pts was associated with
higher incidence of repeat PCI including TLR and TVR and MACE up to
3 years.
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BACKGROUND ACC/AHA coronary lesion classiﬁcation was devel-
oped in 1988 as a method of predicting procedural success and
complications in the angioplasty era. Correlation with short- and
medium-term outcomes during the contemporary percutaneous cor-
onary intervention (PCI) era is not well established. We aimed to
